AAAAAA

   
Results: 1-8 |
Results: 8
RECOMBINANT ADENOVIRUS ENCODING GP100 MODULATES EXPERIMENTAL MELANIN-PROTEIN INDUCED UVEITIS (EMIU)
Authors: CHAN CC LI Y SUN B LI Q MATTESON DM SHEN DB NUSSENBLATT RB ZHAI YF
Citation: Cc. Chan et al., RECOMBINANT ADENOVIRUS ENCODING GP100 MODULATES EXPERIMENTAL MELANIN-PROTEIN INDUCED UVEITIS (EMIU), Journal of autoimmunity, 11(2), 1998, pp. 111-118
CUTTING EDGE - TRANK, A NOVEL CYTOKINE THAT ACTIVATES NF-KAPPA-B AND C-JUN N-TERMINAL KINASE
Authors: HARIDAS V NI J MEAGER A SU J YU GL ZHAI YF KYAW H AKAMA KT HU JR VANELDIK LJ AGGARWAL BB
Citation: V. Haridas et al., CUTTING EDGE - TRANK, A NOVEL CYTOKINE THAT ACTIVATES NF-KAPPA-B AND C-JUN N-TERMINAL KINASE, The Journal of immunology (1950), 161(1), 1998, pp. 1-6
LIGHT, A NOVEL LIGAND FOR LYMPHOTOXIN BETA-RECEPTOR AND TR2 HVEM INDUCES APOPTOSIS AND SUPPRESSES IN-VIVO TUMOR-FORMATION VIA GENE-TRANSFER/
Authors: ZHAI YF GUO RB HSU TL YU GL NI J KWON BS JIANG GW LU JM TAN J UGUSTUS M CARTER K ROJAS L ZHU F LINCOLN C ENDRESS G XING LL WANG S OH KO GENTZ R RUBEN S LIPPMAN ME HSIEH SL YANG DJ
Citation: Yf. Zhai et al., LIGHT, A NOVEL LIGAND FOR LYMPHOTOXIN BETA-RECEPTOR AND TR2 HVEM INDUCES APOPTOSIS AND SUPPRESSES IN-VIVO TUMOR-FORMATION VIA GENE-TRANSFER/, The Journal of clinical investigation, 102(6), 1998, pp. 1142-1151
CLONING AND CHARACTERIZATION OF THE GENES ENCODING THE MURINE HOMOLOGS OF THE HUMAN-MELANOMA ANTIGENS MART1 AND GP100
Authors: ZHAI YF YANG JC SPIESS P NISHIMURA MI OVERWIJK WW ROBERTS B RESTIFO NP ROSENBERG SA
Citation: Yf. Zhai et al., CLONING AND CHARACTERIZATION OF THE GENES ENCODING THE MURINE HOMOLOGS OF THE HUMAN-MELANOMA ANTIGENS MART1 AND GP100, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 15-25
ANTIGEN-SPECIFIC TUMOR VACCINES - DEVELOPMENT AND CHARACTERIZATION OFRECOMBINANT ADENOVIRUSES ENCODING MART1 OR GP100 FOR CANCER-THERAPY
Authors: ZHAI YF YANG JC KAWAKAMI Y SPIESS P WADSWORTH SC CARDOZA LM COUTURE LA SMITH AE ROSENBERG SA
Citation: Yf. Zhai et al., ANTIGEN-SPECIFIC TUMOR VACCINES - DEVELOPMENT AND CHARACTERIZATION OFRECOMBINANT ADENOVIRUSES ENCODING MART1 OR GP100 FOR CANCER-THERAPY, The Journal of immunology, 156(2), 1996, pp. 700-710
THERAPEUTIC ANTITUMOR RESPONSE AFTER IMMUNIZATION WITH A RECOMBINANT ADENOVIRUS ENCODING A MODEL TUMOR-ASSOCIATED ANTIGEN
Authors: CHEN PW WANG M BRONTE V ZHAI YF ROSENBERG SA RESTIFO NP
Citation: Pw. Chen et al., THERAPEUTIC ANTITUMOR RESPONSE AFTER IMMUNIZATION WITH A RECOMBINANT ADENOVIRUS ENCODING A MODEL TUMOR-ASSOCIATED ANTIGEN, The Journal of immunology, 156(1), 1996, pp. 224-231
LAR-PTPASE CDNA TRANSFECTION SUPPRESSION OF TUMOR-GROWTH OF NEU ONCOGENE-TRANSFORMED HUMAN BREAST-CARCINOMA CELLS
Authors: ZHAI YF WIRTH J KANG SM WELSCH CW ESSELMAN WJ
Citation: Yf. Zhai et al., LAR-PTPASE CDNA TRANSFECTION SUPPRESSION OF TUMOR-GROWTH OF NEU ONCOGENE-TRANSFORMED HUMAN BREAST-CARCINOMA CELLS, Molecular carcinogenesis, 14(2), 1995, pp. 103-110
INCREASED EXPRESSION OF SPECIFIC PROTEIN-TYROSINE PHOSPHATASES IN HUMAN BREAST EPITHELIAL-CELLS NEOPLASTICALLY TRANSFORMED BY THE NEU ONCOGENE
Authors: ZHAI YF BEITTENMILLER H WANG BC GOULD MN OAKLEY C ESSELMAN WJ WELSCH CW
Citation: Yf. Zhai et al., INCREASED EXPRESSION OF SPECIFIC PROTEIN-TYROSINE PHOSPHATASES IN HUMAN BREAST EPITHELIAL-CELLS NEOPLASTICALLY TRANSFORMED BY THE NEU ONCOGENE, Cancer research, 53(10), 1993, pp. 2272-2278
Risultati: 1-8 |